シングルセル解析の市場規模、シェア、動向分析：製品別、技術別、用途別、エンドユーザー別、地域別の展望、競合戦略、セグメント予測（～2030年）

世界のシングルセル解析の市場規模は、2030年までに14.6%のCAGRで推移し、105億7,000万米ドルに達すると予測されています。がんの有病率の上昇によって当市場の成長が促進されています。

当レポートでは、世界のシングルセル解析市場を調査し、市場概要、市場力学、市場の展望、セグメント別・地域別の分析、主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

• イントロダクション
• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
  • 課題
• COVID-19のシングルセル解析市場への影響
• 市場動向

第5章 世界のシングルセル解析市場：製品別（2019年～2030年）

• 消耗品
  • ビーズ
  • マイクロプレート
  • 試薬
  • アッセイキット
  • その他（培養皿、フラスコ、チューブ、キュベット、クライオバイアル、ろ過装置、シャーレ、インサート、ディスク）
• 機器
  • フローサイトメーター
  • NGSシステム
  • PCR機器
  • 分光光度計
  • 顕微鏡
  • セルカウンター
  • HCSシステム
  • マイクロアレイ
  • その他
  • シングルセル解析：細胞タイプ別
  • ヒト細胞
  • 動物細胞
  • 微生物細胞

第6章 世界のシングルセル解析市場：技術別（2019年～2030年）

• フローサイトメトリー
• 次世代シーケンシング
• ポリメラーゼ連鎖反応
• 顕微鏡検査
• 質量分析
• その他

第7章 世界のシングルセル解析市場：用途別（2019年～2030年）

• 研究用途
  • がん
  • 免疫学
  • 神経学
  • 幹細胞
  • その他
• 医療用途
  • 非侵襲的出生前診断
  • 体外受精
  • 循環腫瘍細胞の検出

第8章 世界のシングルセル解析市場：エンドユーザー別（2019年～2030年）

• 学術研究ラボ
• バイオテクノロジー・製薬企業
• 病院・診断ラボ
• 細胞バンク・IVFセンター

第9章 世界のシングルセル解析市場：地域別（2019年～2030年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • その他
• その他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

• イントロダクション
• 市場シェア分析：主要企業別
• 競合シナリオ
  • 製品の発売
  • パートナーシップ、コラボレーション、契約
  • 買収
  • 拡張
  • その他の開発

第11章 企業プロファイル

• 10x Genomics
• Agilent Technologies, Inc.
• Apogee Flow Systems Ltd.
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories
• Corning Incorporated
• Cytek Biosciences
• Danaher Corporation
• Fluidigm Corporation
• Fluxion Biosciences
• Illumina, Inc.
• Luminex Corporation
• Menarini Silicon Biosystems, Inc.
• Merck KGAA
• NanoCellect Biomedical
• On-chip Biotechnologies Co., Ltd.
• Oxford Nanopore Technologies
• Promega Corporation
• QIAGEN N.V.
• Rarecyte Inc
• Sartorius AG
• Takara Bio
• Tecan Group Ltd.
• Thermo Fisher Scientific, Inc.

第12章 付録

Global single cell analysis market is projected to be worth USD 10.57 billion by 2030

According to SPER Market Research, the single cell analysis market is estimated to reach USD 10.57 billion by 2030 with a CAGR of 14.6%. Single cell analysis is the study of transcriptomics, genomics and other cellular interactions at a single cell level. The rising prevalence of cancer creates urgent need for better diagnostic models which can be served by single cell analysis.

Impact of COVID-19 on the Single Cell Analysis Market

The COVID-19 pandemic has prompted the development and manufacturing of vaccines. The government initiatives to meet the vaccine demand has increased the adoption of single-cell analysis product. Single-cell analysis technique assist the researchers to understand immune response on single-cell basis in order to evaluate prognosis of disease, identify diagnostic markers and develop therapeutic interventions.

Scope of the report:

• Market size available for years: 2019-2030
• Base year considered: 2021
• Forecast period: 2022-2030

• Segments covered: By Product, By Technology, By Application, By End User

• Geographies covered: North America, Europe, APAC, Latin America and the Middle East & Africa

• Companies Covered: 10x Genomics, Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Corning Incorporated, Cytek Biosciences, Danaher Corporation, Fluidigm Corporation, Fluxion Biosciences, Illumina, Inc., Luminex Corporation, Menarini Silicon Biosystems, Inc., Merck KGAA, NanoCellect Biomedical, On-chip Biotechnologies Co., Ltd., Oxford Nanopore Technologies, Promega Corporation, QIAGEN N.V., Rarecyte Inc, Sartorius AG, Takara Bio, Tecan Group Ltd., Thermo Fisher Scientific, Inc.

Driver: Rising prevalence of Cancer

The prevalence of Cancer is increasing across the globe creating urgent need for extensive research and development for better diagnosis and therapeutic interventions. Single-cell analysis provides accurate diagnosis of cancer and enables early treatment. Single-cell analysis can be used in monitoring the progression of tumors.

Restraints: Budget constraints for expensive products

Single-cell analysis is an expensive technique as it requires to maintain quality standards and comply with the regulatory recommended guidelines. Additionally, maintenance and indirect costs also add up in total cost of ownership. Many academic laboratories can not afford such costly analytical instruments which restraints the growth of this market.

Opportunity: Growth potential in single cell sequencing

Single cell sequencing provides a powerful technology to identify biomarkers for the diagnosis of diseases and monitor the progression of disease as well as response of patient to the treatment. Due to the quality of analysis, there is a huge growth potential in this market. Thus, companies are focusing on advancement of more single cell sequencing instruments in the forecast period.

Single Cell Analysis Market by Product:

Based on product, market has been segmented into Consumables (Beads, Microplates, Reagents, Assay Kits [Immunoassays, Cell-based Assays], Other Consumables), Instruments (Flow Cytometers, NGS Systems, PCR Instruments, Spectrophotometers, Microscopes, Cell Counters, HCS Systems, Microarrays, Other Instruments, Single Cell Analysis, by Cell Type, Human Cells, Animal Cells, Microbial Cells)

Single Cell Analysis Market by Technique:

Based on technique, the market is segmented into Flow Cytometry, Next-generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, Other Techniques

Single Cell Analysis Market by Application:

Based on application, the market is segmented into Research Applications (Cancer, Immunology, Neurology, Stem Cell, Other Research Applications), Medical Applications (Noninvasive Prenatal Diagnosis, in Vitro Fertilization, Circulating Tumor Cell Detection)

Single Cell Analysis Market by End User:

Based on end user, the market is segmented into Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks & IVF Centers, Academic & research laboratories have the largest share of this market by end user owing to rising number of medical colleges and increasing funding for research in life science.

Single Cell Analysis Market by Region:

North America owns the largest share of this market due to factors such as rising funding for research & development, high adoption for new technology and presence of key players of this market in North America.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
  • 4.2.4. Challenges
• 4.3. COVID-19 Impact of the Single Cell Analysis Market
• 4.4. Market Trends

5. Global Single Cell Analysis Market, By Product, 2019-2030 (USD Million)

• 5.1. Consumables
  • 5.1.1. Beads
  • 5.1.2. Microplates
  • 5.1.3. Reagents
  • 5.1.4. Assay Kits
    • 5.1.4.1. Immunoassays
    • 5.1.4.2. Cell-based Assays
  • 5.1.5. Other Consumables (Culture Dishes, Flasks, Tubes, Cuvettes, Cryovials, Filtration Apparatus, Petri Dishes, Inserts, and Discs)
• 5.2. Instruments
  • 5.2.1. Flow Cytometers
  • 5.2.2. NGS Systems
  • 5.2.3. PCR Instruments
  • 5.2.4. Spectrophotometers
  • 5.2.5. Microscopes
  • 5.2.6. Cell Counters
  • 5.2.7. HCS Systems
  • 5.2.8. Microarrays
  • 5.2.9. Other Instruments
  • 5.2.10. Single Cell Analysis, by Cell Type
  • 5.2.11. Human Cells
  • 5.2.12. Animal Cells
  • 5.2.13. Microbial Cells

6. Global Single Cell Analysis Market, By Technique, 2019-2030 (USD Million)

• 6.1. Flow Cytometry
• 6.2. Next-generation Sequencing
• 6.3. Polymerase Chain Reaction
• 6.4. Microscopy
• 6.5. Mass Spectrometry
• 6.6. Other Techniques

7. Global Single Cell Analysis Market, By Application, 2019-2030 (USD Million)

• 7.1. Research Applications
  • 7.1.1. Cancer
  • 7.1.2. Immunology
  • 7.1.3. Neurology
  • 7.1.4. Stem Cell
  • 7.1.5. Other Research Applications
• 7.2. Medical Applications
  • 7.2.1. Noninvasive Prenatal Diagnosis
  • 7.2.2. in Vitro Fertilization
  • 7.2.3. Circulating Tumor Cell Detection

8. Global Single Cell Analysis Market, By End User, 2019-2030 (USD Million)

• 8.1. Academic & Research Laboratories
• 8.2. Biotechnology & Pharmaceutical Companies
• 8.3. Hospitals & Diagnostic Laboratories
• 8.4. Cell Banks & IVF Centers

9. Global Single Cell Analysis Market, By Geography, 2019-2030 (USD Million)

• 9.1. North America
  • 9.1.1. US
  • 9.1.2. Canada
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. UK
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of the World
  • 9.4.1. Latin America
  • 9.4.2. Middle East & Africa

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Market Share Analysis, By Key Players
• 10.3. Competitive Scenario
  • 10.3.1. Product Launches
  • 10.3.2. Partnerships, Collaborations and Agreements
  • 10.3.3. Acquisitions
  • 10.3.4. Expansions
  • 10.3.5. Other Developments

11. Company Profiles

• 11.1. 10x Genomics
• 11.2. Agilent Technologies, Inc.
• 11.3. Apogee Flow Systems Ltd.
• 11.4. Becton, Dickinson and Company
• 11.5. BioMerieux SA
• 11.6. Bio-Rad Laboratories
• 11.7. Corning Incorporated
• 11.8. Cytek Biosciences
• 11.9. Danaher Corporation
• 11.10. Fluidigm Corporation
• 11.11. Fluxion Biosciences
• 11.12. Illumina, Inc.
• 11.13. Luminex Corporation
• 11.14. Menarini Silicon Biosystems, Inc.
• 11.15. Merck KGAA
• 11.16. NanoCellect Biomedical
• 11.17. On-chip Biotechnologies Co., Ltd.
• 11.18. Oxford Nanopore Technologies
• 11.19. Promega Corporation
• 11.20. QIAGEN N.V.
• 11.21. Rarecyte Inc
• 11.22. Sartorius AG
• 11.23. Takara Bio
• 11.24. Tecan Group Ltd.
• 11.25. Thermo Fisher Scientific, Inc.

12. Appendix